Recall about reduced biotin interference threshold for the recently launched Elecsys FT4 III Assays. The described threshold in the method sheet is less or equal to 409 nmol/l or less or equal to 100 ng/ml of biotin in a sample. However, for the currently available products (lots listed), the threshold is less or equal to 81.8 nmol/l or less or equal to 20 ng/ml (same as previous FT4 II). In patient samples with biotin concentrations of more or equal to 266 nmol/l or more or equal to 65 ng/ml, FT4 recovery could lead to a difference of less than 20%. The overall performance of the Elecsys FT4 III Assays, including the improved robustness against unspecific streptavidin interference, is not impacted (confirmed by the manufacturer).